Recent progress in the use of glycine transporter-1 inhibitors for the treatment of central and peripheral nervous system diseases

By Slassi Abdelmalik   Egle Ian  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 2, 2004-02 ,pp. : 201-214

Informa Healthcare

Access to resources Recommend Favorite

Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System

By  

Current Neuropharmacology, Vol. 16, Iss. 2, 2018-01 ,pp. : 210-221

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Potential of Sigma (σ ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the Evidence

By  

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 884-901

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in 5-HT6 receptor antagonists for the treatment of CNS diseases

By Slassi Abdelmalik   Isaac Methvin   O’Brien Anne  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 513-527

Informa Healthcare

Access to resources Recommend Favorite

The Recent Development of 7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2134-2151

Bentham Science Publishers

Access to resources Recommend Favorite